<DOC>
	<DOCNO>NCT00871052</DOCNO>
	<brief_summary>Polymorphic light eruption ( PLE ) photodermatosis extremely high prevalence , particularly among young woman ( 20 % ) . The disease characterize itchy skin lesion sun-exposed body sit occur sun exposure mostly spring early summer . Its etiopathogenesis unknown resistance ultraviolet radiation ( UVR ) -induced immunosuppression subsequent immune reaction skin photoneoantigens suggest . The phenomenon UVR-induced immunosuppression ( suppression CHS ) well know many year . Recent finding show regulatory T cell ( CD4+CD25+FoxP3+ ) ( Tregs ) , subset T helper cell , crucial UVR-induced immunosuppression . However , requirement maintenance peripheral CD4+CD25+ T cell , important suppression immune response , still incompletely understood . Recent work suggest cutaneous RANKL might physiologic miss link couple UVR immunosuppression . Epidermal RANKL , express keratinocytes inflamed skin due e.g . UVR exposure show control number Tregs via activation dendritic cell , hereby mediate UVR-induced immunosuppression ( e.g . suppression allergic contact hypersensitivity response ) . In addition suppression local cutaneous hyperallergic response , development systemic autoimmunity suppress . A strong inducer RANKL expression Tregs vitamin D3 report immunosuppressive effect . Interestingly , patient autoimmune disorder ( e.g . lupus erythematosus ) may exhibit reduced vitamin D3 blood level . This randomized , double blind left-right body side experimental comparison study design assess preventive effect vitamin D3 analogue calcipotriol patient PLE . The hypothesis test treatment calcipotriol-containing cream prevent UVR-induced development PLE skin lesion . Better insight pathogenesis PLE may give clue develop new therapeutic strategy .</brief_summary>
	<brief_title>Calcipotriol Polymorphic Light Eruption</brief_title>
	<detailed_description>PLE patient recruit Photodermatology Unit Department Dermatology , Medical University Graz , Austria . Eligible patient identify diagnosis-related computer-assisted search electronic patient chart system Unit . The diagnosis PLE verify patient 's history , clinical symptom , histologic finding , laboratory study and/or phototesting procedure . A calcipotriol-cream placebo cream use study . Fifteen PLE patient enrol . On day 1 , individual minimal erythema dose ( MED ) assess patient ' skin exposure test ladder solar-simulated UVR produce xenon arc source ( Oriel Corp. Darmstadt , Germany ) . From day 2 5 , 0.5 individual MED exposures ( increase 0 30 % per exposure , depend erythema response precede dose ) give total four 10-by-10 cm skin test field symmetrically locate , individual PLE predilection sit trunk extremity . These test field pretreated randomized double-blinded fashion either calcipotriol cream placebo cream ( twice day ) 7 day start phototesting .</detailed_description>
	<mesh_term>Exanthema</mesh_term>
	<mesh_term>Dermatitis , Contact</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<criteria>Diagnosis PLE either typical history and/or typical histology lesion and/or positive phototesting result Age &gt; 18 year Presence history malignant skin tumor Dysplastic melanocytic nevus syndrome Photosensitive disease porphyria , chronic actinic dermatitis , Xeroderma pigmentosum , basal cell nevus syndrome , others Autoimmune disorder Lupus erythematosus dermatomyositis Psychiatric disorder Immune deficiency systemic treatment steroid and/or immunosuppressive drug Pregnancy lactation Antinuclear antibodies UV exposure test field within 8 week study start General poor health status Severe liver renal disease , disorder therapy calcium metabolism vitamin D containing drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Polymorphic light eruption</keyword>
	<keyword>UV radiation</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>Immune suppression</keyword>
	<keyword>Prevention</keyword>
</DOC>